Developer docs
API playgroundTry for free, no card

Search company profiles

O2 Concepts

Full company profile

uuid000cq2x

Namestring
O2 Concepts
Legal namestring
O2 Concepts, LLC
Websiteurl
o2-concepts.com
Company typeenum
Private
Founded yearint
2010
Descriptiontext

O2 Concepts is a privately held US medical device manufacturer specializing in portable oxygen concentrators (POCs) for patients with chronic respiratory conditions such as COPD. Founded in 2010 and headquartered in Oklahoma City, the company operates US-based manufacturing and R&D facilities (including a Connecticut site in Middlebury) and sells through durable medical equipment (DME) providers, hospital groups, and academic medical centers in the United States, with recent expansion into the EU (post-MDR certification, July 2025) and Canada (post-MDSAP approval).

The company's product portfolio centers on the Oxlife line, including the flagship Oxlife INDEPENDENCE (3.0 LPM continuous flow, 12 pulse settings, five-year warranty) and the Oxlife LIBERTY2 and LIBERTY wearable POCs (up to 2.0 LPM continuous flow and 1–10 pulse settings). All current devices embed O2 Concepts' proprietary DNA Technology (Dynamic Network Analysis)—a device-initiated cellular platform providing 24/7 remote asset and clinical monitoring, GPS tracking, geofencing, and adherence alerts—and patented Energy Smart Technology for oxygen delivery and battery performance. The Oxlife LIBERTY2 is differentiated as the only wearable POC with 2.0 LPM continuous flow and CPAP compatibility.

Revenue is generated primarily through hardware sales of POCs (billed under DME reimbursement codes E1390 and E1392), with a recurring-services component from the DNA Technology monitoring platform. Distribution is channel-mediated: the 2023 partnership with VGM & Associates exposes O2 Concepts to roughly 3,000 DME providers across nearly 7,000 locations in the US, complemented by direct enterprise sales to healthcare systems and, since July 2025, by European distributors. The company is founder/management-controlled (CEO Elby Beal), with no disclosed institutional capital, M&A activity, or public listing, and counts on its domestic manufacturing footprint and regulatory approvals as competitive differentiators.

Short descriptiontext

O2 Concepts is a US-based manufacturer of portable oxygen concentrators (Oxlife INDEPENDENCE, LIBERTY, LIBERTY2) with proprietary DNA Technology for device-initiated remote monitoring, serving DME providers, hospitals, and respiratory patients in the US, EU, and Canada.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersMiddlebury, United States
HQ citystring
Middlebury
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
portable oxygen concentrators, durable medical equipment, respiratory therapy devices, remote patient monitoring, medical device manufacturing
Industry3 codes
PRIMARYHLAHAGAD
Oxygen Therapy Systems (Concentrators, Cylinders, Liquid O2, HFNC)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Respiratory & Sleep Therapy Devices
SECONDARYHLAKANAM
Home Ventilation, Oxygen Therapy & Respiratory DME Clinical Management
SECONDARYHLAHAGAI
Respiratory Monitoring & Oximetry (Capnography, Pulse Oximeters, Respiratory Rate)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Respiratory & Sleep Therapy Devices
NAICS code1 code
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code1 code
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Respiratory Medical Devices
Social media profiles1 record
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Portable Oxygen Concentrator Sales
TypeHardware Sales
Description

Sale of medical devices (POCs) to DMEs, healthcare systems, and homecare providers. Devices include Oxlife Independence, Oxlife Liberty, and Oxlife Liberty2 with varying continuous flow and pulse dose capabilities.

o2-concepts.com
2DNA Technology Remote Monitoring Services
TypeSubscription Recurring
Description

Device-initiated remote asset and clinical monitoring services enabling providers with daily critical data for operating efficiency, asset management, inventory control, and improved patient outcomes.

o2-concepts.com
3International Distribution
TypeHardware Sales
Description

Revenue from expanded EU market following MDR certification, distributed through leading EU distributors for Oxlife Liberty and Oxlife Independence devices with DNA Technology.

hme-business.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
Pricing details1 tier
1Billed under medical equipment codes E1390 and E1392
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Devices qualify for standard DME billing codes, enabling reimbursement through insurance and Medicare.

o2-concepts.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1Oxlife
Description

Product line of portable oxygen concentrators including LIBERTY2, LIBERTY, and INDEPENDENCE devices.

o2-concepts.com
+2 more records
Core offering1 text field

O2 Concepts manufactures and sells portable oxygen concentrators (POCs) under the Oxlife brand, including the Oxlife INDEPENDENCE (3.0 LPM continuous flow), Oxlife LIBERTY, and Oxlife LIBERTY2 (2.0 LPM continuous flow, the only wearable POC with this capability). All devices integrate the proprietary DNA Technology platform, providing device-initiated cellular remote monitoring, GPS tracking, and geofencing for healthcare providers and DME suppliers. The company manufactures in the United States and sells to durable medical equipment providers, hospital groups, and academic medical centers in the US, EU, and Canada.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Reduced COPD readmissions through timely clinical interventions based on DNA Technology adherence monitoring
+2 more records
Product overview1 text field

O2 Concepts is a US-based manufacturer of portable oxygen concentrators (POCs) headquartered in Oklahoma City with manufacturing operations in Connecticut. The company's product portfolio centers on two main POC lines: the Oxlife INDEPENDENCE (3.0 LPM continuous flow, 12 pulse settings) and the Oxlife LIBERTY/LIBERTY2 series (delivering 2.0 LPM continuous flow in the LIBERTY2 model). All current POC products feature the proprietary DNA Technology platform enabling device-initiated remote monitoring and connectivity. The Oxlife FREEDOM has been discontinued but remains supported. The company emphasizes domestic US manufacturing while expanding into European and Canadian markets following regulatory approvals.

Product and service3 records
1Oxlife LIBERTY2 Portable Oxygen Concentrator
CategoryPortable Oxygen Concentrator (Respiratory Medical Device)
Description

Wearable portable oxygen concentrator delivering 2.0 LPM continuous flow oxygen combined with 1-10 pulse flow settings in a single device for DME providers, clinicians, and patients with chronic respiratory conditions. Features DNA Technology for remote monitoring and is the only wearable continuous flow device allowing CPAP compatibility.

2Oxlife INDEPENDENCE Portable Oxygen Concentrator
CategoryPortable Oxygen Concentrator (Respiratory Medical Device)
Description

Flagship portable oxygen concentrator providing 3.0 LPM continuous flow and 12 pulse settings with patented Energy Smart Technology for healthcare providers and DME suppliers. Supports 24/7 therapy with up to 6 hours of battery life via dual battery configuration, CPAP and BiPAP compatible, and includes a five-year warranty.

3Oxlife LIBERTY Portable Oxygen Concentrator
CategoryPortable Oxygen Concentrator (Respiratory Medical Device)
Description

Advanced portable oxygen concentrator utilizing patented Energy Smart Technology to deliver 1.5 LPM continuous flow and robust pulse dose settings up to 9 in a compact lightweight design, for DME providers and patients with chronic respiratory conditions.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-07-16
Description

To support European expansion following MDR certification, O2 Concepts partnered with leading distributors to bring Oxlife Liberty and Oxlife Independence devices with DNA Technology to high-demand EU markets.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2023-08-09
Description

O2 Concepts partnered with VGM & Associates, the nation's largest and most comprehensive Member Service Organization (MSO) for post-acute healthcare. The partnership expands the VGM Respiratory portfolio with O2 Concepts' innovative POC portfolio and DNA Technology platform, serving VGM's 3,000 provider members with nearly 7,000 locations.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Inogen is the largest pure-play portable oxygen concentrator manufacturer (Rove 6, Inogen One) and the most direct competitor to Oxlife Independence and Liberty lines for ambulatory oxygen patients served through DMEs.

TypeBroad incumbent
Description

SimplyGo and SimplyGo Mini are part of Philips' broad sleep and respiratory portfolio sold through hospital systems and DMEs — overlapping in POC category but as one of many lines within a global medtech incumbent.

TypeBroad incumbent
Description

ResMed Mobi is a wearable POC complementing its dominant sleep apnea franchise. ResMed competes in the same DMEs and patient populations but operates across a much broader respiratory and connected-health portfolio.

TypeDirect peer
Description

DeVilbiss iGO and related POCs target the same DME channel and long-term oxygen therapy population as Oxlife, with similar continuous-flow / pulse-dose product positioning and US-based manufacturing roots.

TypeDirect peer
Description

CAIRE makes the FreeStyle Comfort and Eclipse 5 portable oxygen concentrators distributed through the same HME/DME channel as Oxlife, competing head-to-head on continuous flow and battery life.

TypeBroad incumbent
Description

Invacare's Platinum Mobile and other respiratory products sit alongside its broader mobility and homecare portfolio, overlapping with Oxlife in DME-sold portable oxygen.

TypeEmerging player
Description

Precision Medical manufactures portable oxygen concentrators and related respiratory devices, competing in niche segments of the POC market with overlapping DME distribution.

TypeRegional player
Description

GCE (formerly Gas Control Equipment) is a European-headquartered manufacturer of portable oxygen concentrators and gas handling equipment, providing geographic overlap now that O2 Concepts has obtained EU MDR certification.

TypeEmerging player
Description

3B Medical offers a growing portfolio of sleep and respiratory devices including portable oxygen solutions, competing with Oxlife in the HME channel and increasingly in connected health.

TypeBroad incumbent
Description

React Health distributes respiratory and sleep therapy products to DMEs and homecare providers in the US, with overlapping provider relationships and product adjacencies to Oxlife's portfolio.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

O2 Concepts

Respiratory Medical Deviceso2-concepts.com

O2 Concepts is a US-based manufacturer of portable oxygen concentrators (Oxlife INDEPENDENCE, LIBERTY, LIBERTY2) with proprietary DNA Technology for device-initiated remote monitoring, serving DME providers, hospitals, and respiratory patients in the US, EU, and Canada.

What O2 Concepts does

O2 Concepts is a privately held US medical device manufacturer specializing in portable oxygen concentrators (POCs) for patients with chronic respiratory conditions such as COPD. Founded in 2010 and headquartered in Oklahoma City, the company operates US-based manufacturing and R&D facilities (including a Connecticut site in Middlebury) and sells through durable medical equipment (DME) providers, hospital groups, and academic medical centers in the United States, with recent expansion into the EU (post-MDR certification, July 2025) and Canada (post-MDSAP approval).

The company's product portfolio centers on the Oxlife line, including the flagship Oxlife INDEPENDENCE (3.0 LPM continuous flow, 12 pulse settings, five-year warranty) and the Oxlife LIBERTY2 and LIBERTY wearable POCs (up to 2.0 LPM continuous flow and 1–10 pulse settings). All current devices embed O2 Concepts' proprietary DNA Technology (Dynamic Network Analysis)—a device-initiated cellular platform providing 24/7 remote asset and clinical monitoring, GPS tracking, geofencing, and adherence alerts—and patented Energy Smart Technology for oxygen delivery and battery performance. The Oxlife LIBERTY2 is differentiated as the only wearable POC with 2.0 LPM continuous flow and CPAP compatibility.

Revenue is generated primarily through hardware sales of POCs (billed under DME reimbursement codes E1390 and E1392), with a recurring-services component from the DNA Technology monitoring platform. Distribution is channel-mediated: the 2023 partnership with VGM & Associates exposes O2 Concepts to roughly 3,000 DME providers across nearly 7,000 locations in the US, complemented by direct enterprise sales to healthcare systems and, since July 2025, by European distributors. The company is founder/management-controlled (CEO Elby Beal), with no disclosed institutional capital, M&A activity, or public listing, and counts on its domestic manufacturing footprint and regulatory approvals as competitive differentiators.

O2 Concepts firmographics

Firmographics
Name
O2 Concepts
Legal name
O2 Concepts, LLC
Website
https://o2-concepts.com
Company type
Private
Founded year
2010
Operating status
Operating
Headcount range
11–50 employees
Short description
O2 Concepts is a US-based manufacturer of portable oxygen concentrators (Oxlife INDEPENDENCE, LIBERTY, LIBERTY2) with proprietary DNA Technology for device-initiated remote monitoring, serving DME providers, hospitals, and respiratory patients in the US, EU, and Canada.
Ownership category
akta.pro rank

O2 Concepts industry classification

Industry
Product category
Respiratory Medical Devices
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro industry
PRIMARYHLAHAGAD
Oxygen Therapy Systems (Concentrators, Cylinders, Liquid O2, HFNC)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Respiratory & Sleep Therapy Devices
SECONDARYHLAKANAM
Home Ventilation, Oxygen Therapy & Respiratory DME Clinical Management
SECONDARYHLAHAGAI
Respiratory Monitoring & Oximetry (Capnography, Pulse Oximeters, Respiratory Rate)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Respiratory & Sleep Therapy Devices

Keywords

  • Portable oxygen concentrators
  • Durable medical equipment
  • Respiratory therapy devices
  • Remote patient monitoring
  • Medical device manufacturing

Where O2 Concepts is headquartered

Location

Headquarters

HQ city
Middlebury
HQ country
United States
HQ region
North America

Offices2 records

Markets served

O2 Concepts business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Portable Oxygen Concentrator Sales: Sale of medical devices (POCs) to DMEs, healthcare systems, and homecare providers. Devices include Oxlife Independence, Oxlife Liberty, and Oxlife Liberty2 with varying continuous flow and pulse dose capabilities.
  2. DNA Technology Remote Monitoring Services: Device-initiated remote asset and clinical monitoring services enabling providers with daily critical data for operating efficiency, asset management, inventory control, and improved patient outcomes.
  3. International Distribution: Revenue from expanded EU market following MDR certification, distributed through leading EU distributors for Oxlife Liberty and Oxlife Independence devices with DNA Technology.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goBilled under medical equipment codes E1390 and E1392

Go-to-market motion3 records

Distribution channels4 records

Marketing channels4 records

O2 Concepts product offering

Product offering

Core offering

O2 Concepts manufactures and sells portable oxygen concentrators (POCs) under the Oxlife brand, including the Oxlife INDEPENDENCE (3.0 LPM continuous flow), Oxlife LIBERTY, and Oxlife LIBERTY2 (2.0 LPM continuous flow, the only wearable POC with this capability). All devices integrate the proprietary DNA Technology platform, providing device-initiated cellular remote monitoring, GPS tracking, and geofencing for healthcare providers and DME suppliers. The company manufactures in the United States and sells to durable medical equipment providers, hospital groups, and academic medical centers in the US, EU, and Canada.

Product overview

O2 Concepts is a US-based manufacturer of portable oxygen concentrators (POCs) headquartered in Oklahoma City with manufacturing operations in Connecticut. The company's product portfolio centers on two main POC lines: the Oxlife INDEPENDENCE (3.0 LPM continuous flow, 12 pulse settings) and the Oxlife LIBERTY/LIBERTY2 series (delivering 2.0 LPM continuous flow in the LIBERTY2 model). All current POC products feature the proprietary DNA Technology platform enabling device-initiated remote monitoring and connectivity. The Oxlife FREEDOM has been discontinued but remains supported. The company emphasizes domestic US manufacturing while expanding into European and Canadian markets following regulatory approvals.

Differentiator

Problem solved

Functional benefit

Brands

  • Oxlife: Product line of portable oxygen concentrators including LIBERTY2, LIBERTY, and INDEPENDENCE devices.
  • DNA Technology
  • Energy Smart Technology

Products and services

  • Oxlife LIBERTY2 Portable Oxygen Concentrator Wearable portable oxygen concentrator delivering 2.0 LPM continuous flow oxygen combined with 1-10 pulse flow settings in a single device for DME providers, clinicians, and patients with chronic respiratory conditions. Features DNA Technology for remote monitoring and is the only wearable continuous flow device allowing CPAP compatibility.
  • Oxlife INDEPENDENCE Portable Oxygen Concentrator Flagship portable oxygen concentrator providing 3.0 LPM continuous flow and 12 pulse settings with patented Energy Smart Technology for healthcare providers and DME suppliers. Supports 24/7 therapy with up to 6 hours of battery life via dual battery configuration, CPAP and BiPAP compatible, and includes a five-year warranty.
  • Oxlife LIBERTY Portable Oxygen Concentrator Advanced portable oxygen concentrator utilizing patented Energy Smart Technology to deliver 1.5 LPM continuous flow and robust pulse dose settings up to 9 in a compact lightweight design, for DME providers and patients with chronic respiratory conditions.

Quantifiable outcome

  • Reduced COPD readmissions through timely clinical interventions based on DNA Technology adherence monitoring
  • +2 more outcomes

Companies that use O2 Concepts

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles3 records

O2 Concepts technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

O2 Concepts partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • European DistributorscoreChannel Partner/ Reseller/ Distributor · 16 July 2025To support European expansion following MDR certification, O2 Concepts partnered with leading distributors to bring Oxlife Liberty and Oxlife Independence devices with DNA Technology to high-demand EU markets.
  • VGM & AssociatescoreChannel Partner/ Reseller/ Distributor · 9 August 2023O2 Concepts partnered with VGM & Associates, the nation's largest and most comprehensive Member Service Organization (MSO) for post-acute healthcare. The partnership expands the VGM Respiratory portfolio with O2 Concepts' innovative POC portfolio and DNA Technology platform, serving VGM's 3,000 provider members with nearly 7,000 locations.

Scale indicators4 records

Recent moves7 records

Expansion highlights4 records

O2 Concepts competitors and assessment

Company assessment

Direct peers

  • Inogen: Inogen is the largest pure-play portable oxygen concentrator manufacturer (Rove 6, Inogen One) and the most direct competitor to Oxlife Independence and Liberty lines for ambulatory oxygen patients served through DMEs.
  • Drive DeVilbiss Healthcare: DeVilbiss iGO and related POCs target the same DME channel and long-term oxygen therapy population as Oxlife, with similar continuous-flow / pulse-dose product positioning and US-based manufacturing roots.
  • CAIRE Inc. (Chart Industries): CAIRE makes the FreeStyle Comfort and Eclipse 5 portable oxygen concentrators distributed through the same HME/DME channel as Oxlife, competing head-to-head on continuous flow and battery life.

Broad incumbents

  • Philips Respironics: SimplyGo and SimplyGo Mini are part of Philips' broad sleep and respiratory portfolio sold through hospital systems and DMEs — overlapping in POC category but as one of many lines within a global medtech incumbent.
  • ResMed: ResMed Mobi is a wearable POC complementing its dominant sleep apnea franchise. ResMed competes in the same DMEs and patient populations but operates across a much broader respiratory and connected-health portfolio.
  • Invacare Corporation: Invacare's Platinum Mobile and other respiratory products sit alongside its broader mobility and homecare portfolio, overlapping with Oxlife in DME-sold portable oxygen.
  • React Health (formerly 3B Medical / BMC): React Health distributes respiratory and sleep therapy products to DMEs and homecare providers in the US, with overlapping provider relationships and product adjacencies to Oxlife's portfolio.

Emerging players

  • Precision Medical: Precision Medical manufactures portable oxygen concentrators and related respiratory devices, competing in niche segments of the POC market with overlapping DME distribution.
  • 3B Medical: 3B Medical offers a growing portfolio of sleep and respiratory devices including portable oxygen solutions, competing with Oxlife in the HME channel and increasingly in connected health.

Regional players

  • GCE Group: GCE (formerly Gas Control Equipment) is a European-headquartered manufacturer of portable oxygen concentrators and gas handling equipment, providing geographic overlap now that O2 Concepts has obtained EU MDR certification.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

O2 Concepts social profiles

Digital presence

O2 Concepts compliance and trust

Trust signal

Compliance4 records

O2 Concepts financial estimates

Financial estimate

Revenue estimate

Valuation estimate

O2 Concepts leadership team

Management profile

Number of profiles

Profiles2 records

O2 Concepts funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

O2 Concepts M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about O2 Concepts

What does O2 Concepts do?

O2 Concepts manufactures and sells portable oxygen concentrators (POCs) under the Oxlife brand, including the Oxlife INDEPENDENCE (3.0 LPM continuous flow), Oxlife LIBERTY, and Oxlife LIBERTY2 (2.0 LPM continuous flow, the only wearable POC with this capability). All devices integrate the proprietary DNA Technology platform, providing device-initiated cellular remote monitoring, GPS tracking, and geofencing for healthcare providers and DME suppliers. The company manufactures in the United States and sells to durable medical equipment providers, hospital groups, and academic medical centers in the US, EU, and Canada.

Is O2 Concepts a public or private company?

O2 Concepts is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was O2 Concepts founded?

O2 Concepts was founded in 2010. It employs 11 to 50 people.

Where is O2 Concepts based?

O2 Concepts is headquartered in Middlebury, United States, in the North America region.

How does O2 Concepts make money?

Three revenue lines are on record. Portable Oxygen Concentrator Sales are the primary driver. The others are DNA Technology Remote Monitoring Services and international Distribution.

Who are O2 Concepts's main competitors?

Direct peers on record are Inogen, Drive DeVilbiss Healthcare and CAIRE Inc. (Chart Industries). Broad incumbents are Philips Respironics, ResMed, Invacare Corporation and React Health (formerly 3B Medical / BMC). Emerging players are Precision Medical and 3B Medical. GCE Group is listed as a regional player.

Does O2 Concepts have an API?

No public API is recorded for O2 Concepts.

What industry is O2 Concepts in?

O2 Concepts's product category is Respiratory Medical Devices. Its primary akta.pro industry code is HLAHAGAD, Oxygen Therapy Systems (Concentrators, Cylinders, Liquid O2, HFNC), with a secondary code of HLAKANAM, Home Ventilation, Oxygen Therapy & Respiratory DME Clinical Management. Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Hme-businessO2 Concepts Announces MDR Approval for European Union, ExpansionO2 Concepts, a manufacturer of portable oxygen concentrators headquartered in Oklahoma City with manufacturing operations in Connecticut, has received Medical Device Regulation (MDR) certification from the European Union, enabling the company to market and distribute its Oxlife Liberty POC and Oxlife Independence POC devices with DNA Technology across all EU member countries. The MDR certification, which replaces the former Medical Device Directive 93/42/EEC, confirms the devices meet Europe's most rigorous medical device standards for clinical evaluation, post-market surveillance, and traceability. The company, which also recently obtained MDSAP approval for Health Canada, stated it continues to manufacture domestically while other manufacturers have shifted production to Asia.PR NewswireMedical Oxygen Concentrators Market to Reach USD 7.1 Billion by 2034, Growing at a 6.9% CAGR: Surge in Demand for Sustainable and Cost-Effective Solutions Drives Market Growth | TMRTransparency Market Research published a report projecting the global medical oxygen concentrators market to grow from US$3.4 billion in 2023 to US$7.1 billion by 2034, representing a 6.9% CAGR, driven by rising respiratory disease prevalence, air pollution levels, and post-COVID-19 demand for oxygen therapy. The Asia Pacific region held the largest market share in 2023, with India accounting for a significant portion of pediatric pneumonia deaths globally. The report identifies key market players including CAIRE and O2 Concepts, which recently launched new products and facilities, while noting technological advancements such as AI-powered oxygen delivery and portable devices as future growth drivers.